| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |